Picture of Advanced Proteome Therapeutics logo

APC.H Advanced Proteome Therapeutics News Story

0.000.00%
ca flag iconLast trade - 00:00
FinancialsHighly SpeculativeMicro Cap

Brief: Advanced Proteome Therapeutics And Immunobiochem Enter Into Collaboration And Option Agreement

Feb 7 (Reuters) - Advanced Proteome Therapeutics Corp 
 APC.V : 
    * ADVANCED PROTEOME THERAPEUTICS AND IMMUNOBIOCHEM 
CORPORATION 
ENTER INTO A COLLABORATION AND OPTION AGREEMENT 
    * ADVANCED PROTEOME THERAPEUTICS - CO, IMMUNOBIOCHEM ENTER 
INTO 
COLLABORATION AND OPTION AGREEMENT TO DEVELOP SUPERIOR 
ANTIBODY-DRUG CONJUGATES 
    * ADVANCED PROTEOME THERAPEUTICS - IMMUNOBIOCHEM GRANTED 
RIGHTS TO 
LICENSE PROPRIETARY SITE-SELECTIVE CONJUGATION TECHNOLOGY 
    * ADVANCED PROTEOME THERAPEUTICS CORP - PRE-NEGOTIATED 
LICENSING 
TERMS INCLUDE UPFRONT AND MILESTONE PAYMENTS AND ROYALTIES 
 
Source text for Eikon:  ID:nGNXOODDQa  
Further company coverage:  APC.V  
 
 ((Bangalore.newsroom@thomsonreuters.com;))

Recent news on Advanced Proteome Therapeutics

See all news